Free Trial

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Bought by Aquatic Capital Management LLC

Ryan Specialty logo with Finance background

Aquatic Capital Management LLC grew its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 7,434.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,357 shares of the company's stock after purchasing an additional 44,755 shares during the period. Aquatic Capital Management LLC's holdings in Ryan Specialty were worth $2,910,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. raised its position in Ryan Specialty by 107.5% in the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock valued at $30,504,000 after purchasing an additional 238,064 shares during the period. Bar Harbor Wealth Management raised its holdings in shares of Ryan Specialty by 5.9% during the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company's stock valued at $10,835,000 after buying an additional 9,482 shares during the period. Barclays PLC lifted its position in Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after acquiring an additional 17,267 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Ryan Specialty by 38.1% in the 4th quarter. GAMMA Investing LLC now owns 1,725 shares of the company's stock worth $111,000 after acquiring an additional 476 shares during the period. Finally, Embree Financial Group grew its position in Ryan Specialty by 64.1% in the fourth quarter. Embree Financial Group now owns 83,212 shares of the company's stock valued at $5,339,000 after acquiring an additional 32,500 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.

Analysts Set New Price Targets

RYAN has been the topic of a number of recent research reports. TD Cowen started coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. UBS Group lifted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Barclays reduced their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Finally, Wells Fargo & Company dropped their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, Ryan Specialty presently has a consensus rating of "Hold" and a consensus target price of $75.67.

Get Our Latest Research Report on RYAN

Ryan Specialty Trading Down 6.8 %

NYSE RYAN opened at $64.87 on Monday. The firm has a market capitalization of $16.99 billion, a PE ratio of 94.02, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a one year low of $48.67 and a one year high of $77.16. The company has a 50-day simple moving average of $70.43 and a 200-day simple moving average of $68.93. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The company had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.74%. Ryan Specialty's dividend payout ratio (DPR) is currently 69.57%.

Insider Buying and Selling at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 31,409 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total value of $2,061,686.76. Following the sale, the director now directly owns 2,697 shares in the company, valued at $177,031.08. This trade represents a 92.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines